Smartleaf Asset Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$182K Hold
1,183
0.01% 872
2026
Q1
$102K Sell
1,183
-423
-26% -$42.5K ﹤0.01% 1103
2025
Q4
$162K Buy
1,606
+510
+47% +$45.6K 0.01% 908
2025
Q3
$67.9K Buy
1,096
+678
+162% +$36.9K ﹤0.01% 1253
2025
Q2
$21.3K Sell
418
-65
-13% -$2.9K ﹤0.01% 1526
2025
Q1
$20.8K Buy
483
+81
+20% +$3.5K ﹤0.01% 1582
2024
Q4
$12.3K Buy
402
+232
+136% +$6.53K ﹤0.01% 1908
2024
Q3
$3.89K Sell
170
-374
-69% -$10.6K ﹤0.01% 2230
2024
Q2
$15.8K Buy
+544
New +$12.7K ﹤0.01% 1146

Other funds holding GH

Smartleaf Asset Management's GH Position: Q2 2026 in Review

Smartleaf Asset Management held its Guardant Health (GH) position steady in Q2 2026 at 1,183 shares worth $182K. The position accounts for 0.01% of the portfolio, ranked #872.

Smartleaf Asset Management first reported a position in GH in Q2 2024 and has held it in 9 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Smartleaf Asset Management held 1,183 shares of Guardant Health worth $182K as of Q2 2026.
  • Smartleaf Asset Management left its Guardant Health share count unchanged in Q2 2026.
  • Guardant Health made up 0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #872 holding.
  • Smartleaf Asset Management first reported a position in Guardant Health in Q2 2024 and has held it in 9 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.